SEBTI SAID M has a total of 14 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INST OF MEDICINAL BIOTECHNOLOGY CHINESE ACAD OF MEDICAL SCIENCES, YUHAN CO LTD and CHANDRAN V RAVI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Microorganisms | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Sebti Said M | 14 |
#2 | Hamilton Andrew D | 5 |
#3 | Jove Richard | 3 |
#4 | Cheng Jin Q | 3 |
#5 | Martin Matthew P | 2 |
#6 | Schönbrunn Ernst | 2 |
#7 | Lawrence Nicholas J | 2 |
#8 | Kayser-Bricker Katherine | 2 |
#9 | Lawrence Harshani R | 2 |
#10 | Turkson James | 1 |
Publication | Filing date | Title |
---|---|---|
US2014057913A1 | Aurora kinase inhibitors and methods of making and using thereof | |
US2012035184A1 | Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase I inhibitors | |
US2009318367A1 | Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugs | |
US2008131526A1 | Akt sensitization of cancer cells | |
US2007254318A1 | Inhibition of cell proliferation |